Brian Mark Rheaume LADC

Recommended Articles

• Gastroenteritis: The Treatment Options

  Treatments for gastroenteritis vary depending on the underlying cause. Normally, acute gastritis caused by non-steroidal anti-inflammatory medications and alcohol can be lessened by stopping the usage of such substances. On the other hand, chronic arthritis occurs due to an H. pylori infection,...

• Singing as therapy: how it helps people with Parkinson’s disease

  For a person diagnosed with Parkinson’s disease, their mobility and movement control ability is impaired, such that they will develop tremors. Moreover, getting dressed, eating, writing, brushing teeth, and driving becomes more challenging. Family members of a patient with Parkinson’s disease...

• New DNA Test May Identify Celiac Disease

  As far as healthy living and dieting are concerned, it seems that a gluten-free diet is the latest fad. Invite some friends to dinner, and it will be obvious that at least one of them will have issues with some of the dishes, probably due to gluten availability. This happens because some people...

• How to Prevent UTIs

  A urinary tract infection (UTI) is a common infection in any part of the urinary or renal system (urethra, ureters, bladder, and kidneys). In fact, it is the second most common type of infection among adults. Besides being responsible for over 8 million visits to healthcare professionals every year,...

• Can Appendicitis Affect the Large Intestines?

  The AppendixUnderstanding the location of the appendix in the abdomen will help us understand how appendicitis can affect the organs in proximity to it. The appendix is found in the lower, right abdomen; with one end attached to the large intestine or the caecum. The function of the large intestine...

• Breaking News on the Treatment of Follicular Lymphoma

  Reuters, the international news agency out of London, has announced that the FDA has given a new drug “accelerated approval,” for the treatment of follicular lymphoma.The drug, Aliqopa (copanlisib), showed complete or partial shrinkage of tumors in 59% of study participants during drug studies,...